Group structure
4 companies in 4 countries
Denmark1
Netherlands1
United Kingdom1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
1–25 of 40
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CANAURAL5 mg / g + 5 mg / g + 100000 unit / g + 2.5 mg / g · Suspension | Diethanolamine fusidate, Framycetin, Nystatin, Prednisolone | Canada | Marketed | 2015 |
| COSACTHEN0.25 mg / ml · Solution | Tetracosactide | Canada | Marketed | 2020 |
| DERMACHLOR 4 MOUSSE4 % / w/v · Solution | Chlorhexidine | Canada | Marketed | 2020 |
| DERMACHLOR 4 SHAMPOO4 % / w/v · Shampoo | Chlorhexidine | Canada | Marketed | 2017 |
| DERMACHLOR 4 SPRAY CONDITIONER4 % / w/v · Spray | Chlorhexidine | Canada | Marketed | 2017 |
| DERMACHLOR 4 WIPES4 % / w/v · Wipe | Chlorhexidine | Canada | Marketed | 2017 |
| DEXMEDESED0.5 mg / ml · Solution | Dexmedetomidine | Canada | Marketed | 2022 |
| DORMAZOLAM5 mg / ml · Solution | Midazolam | Canada | Marketed | 2021 |
| DUOTIC1 mg / ml + 10 mg / ml · Gel | Betamethasone, Terbinafine | Canada | Marketed | 2026 |
| EMAVERT10 mg / ml · Solution | Maropitant | Canada | Marketed | 2023 |
| EQUIPALAZONE 1 G1 g / sachet · Powder | Phenylbutazone | Canada | Marketed | 2024 |
| FELIMAZOLE 1.25 MG1.25 mg · Tablet | Thiamazole | Canada | Marketed | 2014 |
| FELIMAZOLE 2.5MG2.5 mg · Tablet | Thiamazole | Canada | Marketed | 2010 |
| FELIMAZOLE 5MG5 mg · Tablet | Thiamazole | Canada | Marketed | 2010 |
| HY-5017 mg / ml · Solution | Hyaluronate | Canada | Marketed | 1998 |
| ISADERM GEL1 mg / g + 5 mg / g · Gel | Betamethasone, Fusidic acid | Canada | Marketed | 2015 |
| ISATHAL EYE GEL10 mg / g · Gel | Fusidic acid | Canada | Marketed | 2015 |
| MIRATAZ2 % / w/w · Ointment | Mirtazapine | Canada | Marketed | 2021 |
| NERFASIN 100100 mg / ml · Solution | Xylazine | Canada | Marketed | 2016 |
| NERFASIN 2020 mg / ml · Solution | Xylazine | Canada | Not marketed | 2016 |
| OSPHOS INJECTION60 mg / ml · Solution | Clodronic acid | Canada | Marketed | 2015 |
| OSURNIA1 mg / ml + 10 mg / ml + 10 mg / ml · Gel | Betamethasone, Florfenicol, Terbinafine | Canada | Marketed | 2015 |
| REXXOLIDE100 mg / ml · Solution | Tulathromycin | Canada | Not marketed | 2022 |
| SUCROMATE EQUINE1.7 mg / ml · Suspension | Deslorelin | Canada | Authorised | |
| TORPHADINE10 mg / ml · Solution | Butorphanol | Canada | Marketed | 2020 |